Vivo Bio Tech Statistics

Total Valuation

Vivo Bio Tech has a market cap or net worth of INR 699.10 million. The enterprise value is 1.23 billion.

Market Cap	699.10M
Enterprise Value	1.23B

Important Dates

The last earnings date was Tuesday, May 20, 2025.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Vivo Bio Tech has 18.38 million shares outstanding. The number of shares has decreased by -8.28% in one year.

Current Share Class	18.38M
Shares Outstanding	18.38M
Shares Change (YoY)	-8.28%
Shares Change (QoQ)	+3.30%
Owned by Insiders (%)	15.33%
Owned by Institutions (%)	n/a
Float	4.28M

Valuation Ratios

The trailing PE ratio is 7.99.

PE Ratio	7.99
Forward PE	n/a
PS Ratio	1.50
PB Ratio	0.90
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	5.91
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.98, with an EV/FCF ratio of -11.75.

EV / Earnings	16.84
EV / Sales	2.63
EV / EBITDA	5.98
EV / EBIT	10.67
EV / FCF	-11.75

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.69.

Current Ratio	1.51
Quick Ratio	0.48
Debt / Equity	0.69
Debt / EBITDA	2.63
Debt / FCF	-5.17
Interest Coverage	1.53

Financial Efficiency

Return on equity (ROE) is 11.01% and return on invested capital (ROIC) is 5.54%.

Return on Equity (ROE)	11.01%
Return on Assets (ROA)	5.12%
Return on Invested Capital (ROIC)	5.54%
Return on Capital Employed (ROCE)	9.96%
Revenue Per Employee	2.90M
Profits Per Employee	452,335
Employee Count	161
Asset Turnover	0.33
Inventory Turnover	0.70

Taxes

In the past 12 months, Vivo Bio Tech has paid 15.10 million in taxes.

Income Tax	15.10M
Effective Tax Rate	17.18%

Stock Price Statistics

The stock price has decreased by -6.00% in the last 52 weeks. The beta is 0.39, so Vivo Bio Tech's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-6.00%
50-Day Moving Average	37.81
200-Day Moving Average	39.08
Relative Strength Index (RSI)	48.94
Average Volume (20 Days)	44,825

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vivo Bio Tech had revenue of INR 466.73 million and earned 72.83 million in profits. Earnings per share was 4.76.

Revenue	466.73M
Gross Profit	408.81M
Operating Income	114.93M
Pretax Income	87.93M
Net Income	72.83M
EBITDA	205.09M
EBIT	114.93M
Earnings Per Share (EPS)	4.76

Full Income Statement

Balance Sheet

The company has 12.81 million in cash and 540.25 million in debt, giving a net cash position of -527.44 million or -28.70 per share.

Cash & Cash Equivalents	12.81M
Total Debt	540.25M
Net Cash	-527.44M
Net Cash Per Share	-28.70
Equity (Book Value)	779.05M
Book Value Per Share	50.58
Working Capital	140.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 118.28 million and capital expenditures -222.70 million, giving a free cash flow of -104.42 million.

Operating Cash Flow	118.28M
Capital Expenditures	-222.70M
Free Cash Flow	-104.42M
FCF Per Share	-5.68

Full Cash Flow Statement

Margins

Gross margin is 87.59%, with operating and profit margins of 24.62% and 15.60%.

Gross Margin	87.59%
Operating Margin	24.62%
Pretax Margin	18.84%
Profit Margin	15.60%
EBITDA Margin	43.94%
EBIT Margin	24.62%
FCF Margin	n/a

Dividends & Yields

Vivo Bio Tech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	8.28%
Shareholder Yield	n/a
Earnings Yield	10.42%
FCF Yield	-14.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 7, 2005. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 7, 2005
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	6